Dean Schorno
Director of Finance/CFO at RIGEL PHARMACEUTICALS, INC.
Net worth: 331 176 $ as of 2024-06-29
Profile
Dean L.
Schorno is currently the Chief Financial Officer & Executive Vice President at Rigel Pharmaceuticals, Inc. Prior to his current position, he served as the Chief Financial Officer & Head-Investor Relations at Genomic Health, Inc. from 2011 to 2014.
From 2015 to 2018, he held the role of Chief Financial Officer & Head-Operations at 23andMe, Inc. Additionally, he was the Chief Financial Officer at Adaptive Biotechnologies Corp.
from 2014 to 2015.
Mr. Schorno completed his graduate degree at Golden Gate University and his undergraduate degree at the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-27 | 40,289 ( 0.23% ) | 331 176 $ | 2024-06-29 |
Dean Schorno active positions
| Companies | Position | Start |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Director of Finance/CFO | 2018-05-28 |
Former positions of Dean Schorno
| Companies | Position | End |
|---|---|---|
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Director of Finance/CFO | 2018-04-30 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Director of Finance/CFO | 2015-08-09 |
| GENOMIC HEALTH, INC. | Director of Finance/CFO | 2014-06-30 |
Training of Dean Schorno
| University of California, Berkeley | Undergraduate Degree |
| Golden Gate University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
- Stock Market
- Insiders
- Dean Schorno
